Member Info for RS2002

Happy Birthday, Nofear

Encouraging news that Nex have positioned themselves and their routes for those wanting to return home for the holidays.

Source: https://www.barryanddistrictnews.co.uk/news/18897401.can-travel-national-express-coaches-december/

Expect to see Trump, after market hours to state that under HIS watch as part of Operation Warp Speed, Moderna is EUA approved. Monday will be one of the greatest short squeezes we witness.

What an exhausting thread to read.

To summarise, the following fundamentals are in place:

1. Debt waivers
2. Additiona liquidity to see Cineworld into Q2 2021
3. Tax rebate of $200m due Q1 2021
4. CARES Act of $200m due in Q2 2021
5. Huge line-up of movies from Q1 2021 when Cineworld will re-open
6. Multiple vaccines which won't just be approved but actively deployed as early as next month
7. Governments advising the public that "come spring next year normality can resume"
8. Mooky being validated and demonstrating credibility over some with an agenda, who were procaliming otherwise

vs

IDW attempting to drive down investor sentiment and confidence to promote some foolish enough to sell given the above mitigants.

One poster, Guitarman had £200k to play with and an opportunity to buy at 17p; if he hadn't listened to the noise from some, he would be sitting on £647k based on the current share price of 55p.

In a welcome twist, it seems the U.K. is now progressing with MHRA review and approvals for the Oxford/AZ vaccine.

Source: https://www.bbc.co.uk/news/uk-55096434

So the FDA in the US may call for a further trial but the U.K. may not, it seems.

The recent FDA and MHRA approval submissions have been for Pfizer/BioNTech and Moderna. These remain on track as follows:

- MHRA Approvals: week commencing 30/12, given Health Secretary Matt Han****’s claim it could be ready for administration as early as 01/12

- FDA Approvals: week commencing 07/12 given the FDA meeting is set for 10/12 via the NHS

Both of these reviews/approvals decisions do NOT have Oxford/AstraZeneca in mind, at this stage. That vaccine has NOT been submitted for regulatory approvals. This the recent new stream will not detract investors particularly given advanced Brexit talk of a fishery deal suggesting an imminent trade deal, and Bloomberg has quoted Oxford won’t be derailed from its approval, even if they do go through a further trial.

“ The development is unlikely to hold up regulatory approval in the UK, Mr Soriot said”

Source: https://www.bloomberg.com/news/articles/2020-11-26/astra-likely-to-run-fresh-global-covid-vaccine-trial-ceo-says

Investors, I suspect will be taking positions ahead of news that could land as early as Monday.

Morning NoFear,

The sentiment is just too strong at the moment for this to decline.

- Liqudidity crisis over
- 2021 biggest backlog of movies to date
- Multiple vaccines with imminient approvals and rollout next month
- Cineworld being prudish with their spend despite the near $1bn (factoring $200m CARES Act due next year)
- Biden suggesting STIMULUS being delivered this side of Xmas

My average is 35p and I'm holding.

I'm really pleased my portfolio is pretty diverse and is doing well, across all sectors.

I'm invested in most recovery plays which I'm sure others are, too but one of my dark horses is Capital and Regional (CapReg).

They are a British commercial landlord, mostly shopping centres. That would strike fear in many investors given the huge shift we have seen exacerbated to e-commerce/online. That said, CapReg have some really good tenants who I see will survive and continue to thrive post covid. The likes of pharmacies, Boots, Superdrug to big retailers like TK Max and supermarkets like Lidl.

What they are also engaged in is conversation with the NHS on potential health centres; perhaps I'm reading too much into this but to me that could lead to vaccine centres as they are in the process of securing one site for the NHS, some 20,000 sqft but also 3-4 more as well.

Take a look over here and read through the end of year report which reveals their NAV should be 250p+ so they are really oversold at the moment. Their current SP is 55p and just back in June when we had our previous recovery it was trading at 135p (2.4x the current SP).

https://www.lse.co.uk/ShareChat.asp?ShareTicker=CAL&share=Capital-and-Regional

As always, DYOR and invest only what you can afford to lose.

The sentiment is looking really strong at the moment.

A quick check on earlier trading history when previous funding issues were alleviated?

Previous movement in just FIVE (5) trading days

22 May 2020 = 58p
26 May 2020 = 69p
27 May 2020 = 77p
28 May 2020 = 102p intra-day high

Cineworld have delivered some fantastic news to see them through this pandemic and into Q1 2021 where we can expect to see a huge recovery not just in leisure and hospitality but across all industries.

A real monumental moment for holders so well done for holding and ignoring the noise from those with shorts who are going to be feeling the burn this week.

- Additional $200m from the US CARES Act that will come Q2 2021 to ADD to the $750m the BoD have secured
- Dividend being restored - BoD to update

Get those marshmallows out!

This thread aged well, didn’t it?

Well done to fellow investors who could see the woods for the trees.

The Cineworld BoD have $750m + $200m CARES Act money so close to $1bn of liquidity, secured.

2021 is going to be an incredible year and recovery for Cineworld and fellow investors.

Good find, NoFear.

Our Health Secretary, Matt Han**** has advised that the approval process via MHRA could see Pfizer and BioNTech’s vaccine ready by 01/12 - a week away.

@investroid

My earlier comment was tongue in cheek but stands; you calling out the liquidity crisis isn’t breaking news. The market has known the H1 results since Cineworld posted this 24 September. The news received on Friday, last week on multiple lending sources coming to focus is going to be received positively by the markets.

On the 9th Nov, two weeks ago you came onto this BB to declare that you were back in.

This thread with your regurgitated posts on Cineworld’s debt and liquidity were all declared and public knowledge in September when Cineworld published H1 results.

You call out others for ramping when they don’t align to your CURRENT entry or trading strategy. Thus, Moola is absolutely correct when he says you are wishy washy; you flip flop between narratives to suit your current trading strategy. The concerns you posted were well known but you got back in. What changed since 2 weeks to encourage you to post up stale news on liquidity and debt financing now?

Answer? Your current position.

What you posted 2 weeks ago:

“AMC may go bust, but Cineworld, unlikely. They may need to raise more debt, refinance, something like that but I am confident they can weather out this storm into Q1/Q2 next year when many scientists are now starting to say as of Monday, will be when we return to business as normal for all of us.”

“...getting around 80p from here; doable and I've bet £30k on it at a 38p average.”

“I can't think of a better recovery play at these levels, I hope my gamble isn't wrong. If it drops, I'll buy more, but I think the risk of bankruptcy has dissipated as we find ourselves with a root out of the pandemic. Long hold it is.”

What can be taken is, you saw the ride up to 50s perhaps 60s from your 38p entry and you sold. Now with the recent news on multiple lending options coming to surface, the fear of missing out is too much for you.

Now you’ve come to beat this stock down, deramp to re-enter at which point you will be singing it’s praises again.

Your credibility is non-existent.

I don’t wish ill on you nor anyone else for that matter, but your opinion is just that, one that changes with the wind, depending on your current position.

Great post, Investroid.

Your thread subtly illustrates why having multiple competing offers to address the liquidity crisis will be seen as positive by the market, tomorrow.

You’re not alone.

The market will react well this actual NEWS. Many have been rehashing old news or further speculation, convinced it will be seen as actual and worse are the ones who unintentionally go to highlight just how important having multiple offers for additional liquidity if is.

The facts?

1. The news from The Times is an opinion not from an analyst but a journalist. It reports OLD news and speculation on the recovery of Cineworld based on an earlier advertised estimate on cash burn.

2. The news that broke Friday was NEW. It cited multiple new lenders competing with existing lenders propping Cineworld as imminent vaccines processing becomes front and center.

Now if you’re impartial, you’ll ask yourself this, will the market react to positive new news or on old news wrapped in speculation?

Roll on Monday.

The timetable has been afforded by the US Head of Vaccine Programme, Dr Moncef Slaou.

This would be officially BEFORE winter which starts 21 December in the northern hemisphere.

Source: https://www.bbc.co.uk/news/world-us-canada-55036381

@IDW

Of course Cineworld are short on cash - this is public knowledge but:

1. If there is a government mandate that supports rent defer why not utilise it?
2. Being conservative with cash is just good business acumen

@IDW

$8,200 Million you quote is post IRFS 16 factoring lease liabilities which if you have read the desperate post from Mo12 will reveal some landlords are raising legal disputes over unpaid rent.

Do you believe Cineworld just cherry picked how they wouldn't pay rent to?

Put 2+2 together, and appreciate Cineworld isn't paying any landlord rent, thus they are not bleeding cash to cover these costs whilst they are not operating.